SFM
UTHR icon

Sphera Funds Management’s United Therapeutics UTHR Stock Holding History

Sphera Funds Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-28,840
Closed -$3.79M – 135
2015
Q3 		$3.79M Hold
28,840
– – 0.48% 42
2015
Q2 		$5.02M Sell
28,840
-20,000
-41% -$3.6M 0.49% 43
2015
Q1 		$8.42M Sell
48,840
-25,000
-34% -$3.81M 0.88% 21
2014
Q4 		$9.56M Sell
73,840
-15,000
-17% -$1.93M 1.63% 11
2014
Q3 		$11.4M Buy
+88,840
New +$9.16M 1.41% 20
2014
Q2 		– Sell
-50,000
Closed -$4.7M – 125
2014
Q1 		$4.7M Buy
+50,000
New +$5.11M 1.07% 15

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Sphera Funds Management's UTHR Position: Q4 2015 in Review

Sphera Funds Management sold out of United Therapeutics (UTHR) in Q4 2015, closing a stake of 28,840 shares — an estimated $3.79M sold.

Sphera Funds Management first reported a position in UTHR in Q1 2014 and held it in 6 quarters. The position peaked at $11.4M in Q3 2014. 386 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • Sphera Funds Management reported no remaining United Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Sphera Funds Management sold 28,840 United Therapeutics shares in Q4 2015, an estimated $3.79M.
  • Sphera Funds Management first reported a position in United Therapeutics in Q1 2014 and held it in 6 quarters.
  • Sphera Funds Management's United Therapeutics position peaked at $11.4M in Q3 2014.
  • 386 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.